Enterprise Value
24.36M
Cash
7.474M
Avg Qtr Burn
-2.45M
Short % of Float
4.34%
Insider Ownership
15.26%
Institutional Own.
11.80%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ibezapolstat Details Clostridioides difficile infection | Phase 3 Initiation |